Abstract 5416: Activity of the pan-PIM kinase inhibitor INCB053914 in models of acute myelogenous leukemia | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract 5416: Activity of the pan-PIM kinase inhibitor INCB053914 in models of acute myelogenous leukemia

Cancer Res (2015) 75 (15_Supplement): 5416.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies

Holly Koblish
Yun-long Li
Niu Shin
Leslie Hall
Qian Wang
Kathy Wang
Maryanne Covington
Cindy Marando
Kevin Bowman
Jason Boer
Krista Burke
Richard Wynn
Alex Margulis
Gary W. Reuther
Que T. Lambert
Valerie Dostalik Roman
Ke Zhang
Hao Feng
Chu-Biao Xue
Sharon Diamond
Greg Hollis
Swamy Yeleswaram
Wenqing Yao
Reid Huber
Kris Vaddi
Peggy Scherle
Kevin D. Bunting

PLOS ONE (2018) 13 (6): e0199108.

Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress

Kshama A. Doshi
Rossana Trotta
Karthika Natarajan
Feyruz V. Rassool
Adriana E. Tron
Dennis Huszar
Danilo Perrotti
Maria R. Baer

Oncotarget (2016) 7 (30): 48280.